The Effect of Spinal Cord Stimulators on Restless Leg Syndrome

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alabama at Birmingham

About this trial

This study aims to evaluate neurophysiological responses and symptom changes in individuals with Restless Legs Syndrome (RLS) and/or chronic pain. Participants will undergo standard clinical assessments including EEG, EMG, h-reflex, SSEP, ERP, and TMS under varying SCS conditions.The study involves 4 arms. Arm 1 are individuals diagnosed with RLS and Healthy Controls. Arm 2 are individuals diagnosed with RLS and have an existing SCS. Arm 3 are individuals diagnosed with RLS and scheduled to receive a SCS. Arm 4 are individuals with chronic pain and have a SCS, but no diagnosis of RLS.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Has Restless Leg Syndrome

No major changes in RLS medications in past 4 weeks

Willing and able to comply with study protocol

Healthy Controls - No RLS diagnosis

Disqualifiers

Any mental or physical limitation that would prevent completing any of the studies

Currently using another device to treat RLS

Unable or unwilling to comply with study protocols

Other medical condition that would put the subject at risk as determined by the investigator

Trial design

Design model

Parallel

Treatments tested in this trial

  • H-Reflex

    Other intervention

    H-reflex - A small electrical stimulus is provided to the leg and foot area and a measurement of the stimulus is taken by the EEG electrodes.

  • Somatosensory evoked potential (SSEP)

    Other intervention

    A small electrical stimulus is provided to a nerve on the body and measured at several places along the nervous system (spinal cord, brain, etc.) with the EMG and EEG electrodes.

  • Vibratory Electrophysiological Response Potential (ERP)

    Other intervention

    stimulation is provided to the ankle with vibration sensations using a device like a buzzer and the recording of the body's responses using the EEG and/or EMG electrodes.

  • Transcranial Magnetic Stimulation (TMS)

    Other intervention

    A small magnetic pulse is used to provide a small amount of electrical stimulation to the nervous system. The EEG and/or EMG electrodes will be used to measure the body's reaction.

  • Spinal Cord Stimulator (SCS) manipulation

    Other intervention

    Spinal cord stimulator will be turned on/off

Treatment groups

50 Participants
are divided into 4 treatment groups
Group A: Arm 1: Assessments and questionnaires onlyActive comparator 4 interventions
Group B: Arm 2: Off-on-offActive comparator 5 interventions
Group C: Arm 3: Off-on-off post-opActive comparator 5 interventions
Group D: Arm 4: On-off-onActive comparator 5 interventions

Trial outcomes

Primary outcomes

1

Changes in H-reflex neurophysiological activity in response to Spinal Cord Stimulation (SCS)

Time frame
Up to 3 Weeks after consent to the study
2

Changes in Somatosensory Evoked Potential (SSEP) activity in response to Spinal Cord Stimulation (SCS)

Time frame
Up to 3 Weeks after consent to the study
3

Changes in Vibratory Electrophysiological Response Potential (ERP) activity in response to Spinal Cord Stimulation (SCS)

Time frame
Up to 3 Weeks after consent to the study
4

Changes in Transcranial Magnetic Stimulation (TMS) activity in response to Spinal Cord Stimulation (SCS)

Time frame
Up to 3 Weeks after consent to the study

Secondary outcomes

1

Changes in self-reported RLS symptoms via International Restless Legs Syndrome (IRLSS) Questionnaire

Time frame
Up to 3 Weeks after consent to the study
2

Changes in self-reported pain symptoms via Promis Questionnaire

Time frame
Up to 3 Weeks after consent to the study
3

Changes in self-reported pain symptoms via PainDetect Questionnaire

Time frame
Up to 3 Weeks after consent to the study

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.